C96.4

C96.4: Sarcoma of dendritic cells (accessory cells)

Billable / specific codeICD-10-CM

C96.4 is a billable, specific ICD-10-CM code for sarcoma of dendritic cells (accessory cells). It is valid for submission on a claim.

Check C96.4 with the rest of the claim: free scrubber

Inclusion terms

Alternative wordings a physician may use in the chart for this same code.

Follicular dendritic cell sarcoma
Interdigitating dendritic cell sarcoma
Langerhans cell sarcoma

Excludes1 inherited from the categories above C96.4

A category’s note binds every code beneath it.

Written on C96: Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue

personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (Z85.79)

Other codes that can never be billed with C96.4

Their own Excludes1 notes name this code, so the conflict is not listed above.

C77Secondary and unspecified malignant neoplasm of lymph nodes

Risk adjustment

C96.4 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

HCC 21 Lymphoma and Other Cancers0.671 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.

Medicare coverage

C96.4 is named in 30 Medicare coverage policies: 30 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
A52479Oral Anticancer Drugs - Policy Article
A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
A54768Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy